Treace Medical Concepts (TMCI) to Release Earnings on Tuesday

Treace Medical Concepts (NASDAQ:TMCI) is set to post its quarterly earnings results after the market closes on Tuesday, May 7th. Analysts expect Treace Medical Concepts to post earnings of ($0.30) per share for the quarter. Treace Medical Concepts has set its FY 2024 guidance at EPS.Individual that wish to listen to the company’s earnings conference call can do so using this link.

Treace Medical Concepts (NASDAQ:TMCI) last posted its quarterly earnings results on Tuesday, February 27th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.01). The business had revenue of $62.20 million for the quarter, compared to the consensus estimate of $60.56 million. Treace Medical Concepts had a negative return on equity of 33.96% and a negative net margin of 26.47%. Treace Medical Concepts’s quarterly revenue was up 24.9% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.08) earnings per share. On average, analysts expect Treace Medical Concepts to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Treace Medical Concepts Trading Up 2.7 %

TMCI opened at $11.00 on Friday. The company has a fifty day moving average price of $12.13 and a two-hundred day moving average price of $11.68. Treace Medical Concepts has a 1-year low of $5.27 and a 1-year high of $27.70. The company has a market cap of $679.36 million, a P/E ratio of -13.58 and a beta of 0.37. The company has a current ratio of 4.40, a quick ratio of 3.76 and a debt-to-equity ratio of 0.38.

About Treace Medical Concepts

Treace Medical Concepts, Inc, a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity.